Collaboration - February 9, 2017
Elekta enters partnership with ESTRO Cancer Foundation
Elekta recently entered into a partnership with the ESTRO [European Society for Radiotherapy & Oncology] Cancer Foundation (ECF) to contribute – hand in hand with various other partners in academia and industry – to the foundation’s mission to ensure that “every patient in Europe will have access to state-of-the-art radiation therapy”. “Elekta’s addition as a […]
MedTech Business - February 7, 2017
Elekta receives FDA clearance
Elekta announces that its Venezia applicator for gynecological brachytherapy has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the treatment of advanced-stage cervical cancer. Venezia received CE Mark approval in November 2016. “There is overwhelming clinical evidence that modern image-guided brachytherapy is an effective treatment modality for cervical cancer. Advanced stage […]
MedTech Award - February 2, 2017
Elekta’s oncology information system receives award
Elekta’s MOSAIQ Oncology Information System (OIS) received the 2017 Category Leader Award for Oncology in the 2017 Best in KLAS: Software and Services report. The awards are based on evaluations collected by KLAS, an independent research firm. Elekta will receive the award during the Healthcare Information and Management Systems Society’s 2017 annual conference and exhibition […]
Agreement - January 2, 2017
Elekta signs agreement with Stockholm County Council and New Karolinska Solna
Elekta, Stockholm’s County Council and New Karolinska Solna have signed a 13-year collaboration agreement which focuses on innovation, joint research, and education and training within advanced radiation therapy. The aim of the agreement is to bring significant improvements in access, quality of care and clinical outcomes for patients suffering from cancer. As part of the […]
MedTech Business - May 30, 2016
Elekta delivers cancer care solutions to New Karolinska
Stockholm County Council (Sweden), announces that Elekta has been awarded the public tender to exclusively equip the Radiation Therapy Department of its new, flagship hospital, the New Karolinska Solna (NKS). Tomas Puusepp, Elekta’s President and CEO, says: “As a Swedish corporation headquartered in Stockholm, and as a world leader in cancer care, we are delighted […]
Regulatory compliance - May 26, 2016
Elekta to pay EUR 8.9 million in legal dispute
On May 23, 2016, an arbitration tribunal in London issued an award in a dispute between two Elekta group companies and humediQ GmbH. The award concludes an arbitration with humediQ arising out of an agreement for the exclusive supply of Identify under the Elekta label, which Elekta entered into in 2011. Identify is a patient […]
